TTRX Turn Therapeutics Inc.

Fundamentals / CIK 0002023016 / USD

Turn Therapeutics Inc. reported $16.35M in total assets and a net loss of $12.77M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TTRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$2.99MFY 2024 Net Income: -$1.77M2024FY 2025 Net Income: -$3.19M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $266K $246K
Total Operating Expenses $5.86M $1.80M
Operating Income -$5.86M -$1.80M
EBITDA -$5.81M -$1.75M
Interest Income $30K $29K
Net Income -$3.19M -$1.77M
Basic EPS -$0.12 -$0.07
Diluted EPS -$0.12 -$0.07
Basic Shares Outstanding 27.7M 26.6M
Diluted Shares Outstanding 27.7M 26.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Research & Development $605K $475K $109K $35K $159K $63K $9.3K $153K
Total Operating Expenses $1.98M $1.63M $1.25M $2.19M $1.91M $1.37M $385K $673K
Operating Income -$1.98M -$1.63M -$1.25M -$2.19M -$1.91M -$1.37M -$385K -$673K
Interest Income $84K -- $50K $14K $5.1K -- $5.2K $6.5K
Interest Expense $341K -- -- -- -- -- -- --
Net Income -$6.23M -$5.85M -$971K $279K -$1.90M -$1.24M -$329K -$666K
Basic EPS -$0.21 -$0.20 -$0.03 -- -$0.07 -$0.05 -$0.01 -$0.03
Diluted EPS -$0.21 -$0.20 -$0.03 -- -$0.07 -$0.05 -$0.01 -$0.03
Basic Shares Outstanding 30.1M 29.8M 29.5M -- 28.0M 27.5M 27.0M 26.6M
Diluted Shares Outstanding 30.1M 29.8M 29.5M -- 28.0M 27.5M 27.0M 26.6M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $4.03M $498K
Cash & Short-Term Investments $4.03M $498K
Total Current Assets $5.20M $1.10M
Intangible Assets $922K $822K
Total Non-Current Assets $6.97M $951K
Total Assets $12.16M $2.05M
Total Current Liabilities $6.00M $708K
Deferred Revenue (Non-Current) $1.44M $1.44M
Total Non-Current Liabilities $1.47M $1.52M
Total Liabilities $7.48M $2.23M
Total Debt (incl. Leases) $80K $121K
Common Stock $2.9K $2.7K
Retained Earnings -$22.39M -$19.20M
Total Stockholders' Equity $4.69M -$177K
Total Equity $4.69M -$177K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2024-12-31
Cash & Cash Equivalents $9.43M $9.95M $11.01M $4.03M $514K $498K
Cash & Short-Term Investments $9.43M $9.95M $11.01M $4.03M $514K $498K
Total Current Assets $11.08M $10.43M $11.45M $5.20M $3.29M $1.10M
Intangible Assets $913K $911K $920K $922K $905K $822K
Total Non-Current Assets $5.27M $6.53M $7.19M $6.97M $1.00M $951K
Total Assets $16.35M $16.96M $18.64M $12.16M $4.30M $2.05M
Short-Term Debt $444K -- -- -- -- --
Total Current Liabilities $3.48M $8.76M $5.13M $6.00M $2.31M $708K
Long-Term Debt $5.74M $6.06M $5.94M -- -- --
Deferred Revenue (Non-Current) $1.44M $1.44M $1.44M $1.44M $1.44M $1.44M
Total Non-Current Liabilities $7.18M $7.51M $7.40M $1.47M $1.48M $1.52M
Total Liabilities $10.66M $16.27M $12.53M $7.48M $3.79M $2.23M
Total Debt (incl. Leases) $6.23M $6.12M $6.01M $80K $91K $121K
Common Stock $3.1K $3.0K $3.0K $2.9K $2.8K $2.7K
Retained Earnings -$35.44M -$29.21M -$23.36M -$22.39M -$22.67M -$19.20M
Total Stockholders' Equity $5.69M $687K $6.12M $4.69M $504K -$177K
Total Equity $5.69M $687K $6.12M $4.69M $504K -$177K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$3.19M -$1.77M
Depreciation & Amortization $53K $47K
Stock-Based Compensation $419K $353K
Operating Cash Flow -$2.56M -$1.36M
Investing Cash Flow -$153K -$99K
Common Stock Issued $6.92M $1.15M
Financing Cash Flow $6.92M $1.15M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Net Income -$6.23M -$5.85M -$971K $279K -$1.90M -$1.24M -$329K -$666K
Stock-Based Compensation $713K $419K $281K $256K $39K $47K $77K --
Operating Cash Flow -$1.55M -$923K -$1.63M -$1.18M -$589K -$500K -$298K --
Investing Cash Flow -$16K -$5.8K -$12K -- -- -- -- --
Common Stock Issued -- -- -- $3.77M $0 $2.15M $998K --
Financing Cash Flow $1.64M $1 $7.79M $3.18M $595K $2.15M $998K --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -68.2% --
Return on Assets (ROA) -26.3% -86.3%
Current Ratio 0.87x 1.55x
Quick Ratio 0.67x 0.70x
Debt to Equity 0.02x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Return on Equity (ROE) -224.4% -1229.6% -62.7% -68.2% -- -- -- --
Return on Assets (ROA) -78.1% -49.8% -20.6% -26.3% -- -- -- --
Current Ratio 3.19x 1.19x 2.23x 0.87x 1.43x -- -- --
Quick Ratio 2.71x 1.14x 2.15x 0.67x 0.22x -- -- --
Debt to Equity 1.09x 8.91x 0.98x 0.02x 0.18x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002023016) · from September 30, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:40 UTC · Open in terminal